Tag Archives: FDA

07.17.13

Industry Trumps Evidence in Tobacco Packaging U-Turn

By | Leave a Comment

This post was written by Holly Jarman, Research Assistant Professor at the University of Michigan.  For more information about this post, please contact hjarman@umich.edu. The original post can be found at the Huffington Post. The government’s disappointing U-turn over plain packaging of tobacco has dealt a blow to campaigners and shows a government attempting to […]

Posted in uncategorized ; Tagged: , , , , , , , , , , , .

07.10.13

Can new FDA graphic warning labels for tobacco pass a first amendment legal challenge?

By | Leave a Comment

A Georgetown public health expert and attorney examines what the FDA must do to prevail. WASHINGTON — When the U.S. Food and Drug Administration (FDA) imposes new graphic warning labels for tobacco products, they can survive a First Amendment challenge if they depict health consequences and their effectiveness is supported by adequate scientific evidence, says […]

Posted in uncategorized ; Tagged: , , , , , , , , , , , , .

06.03.13

O'Neill Institute's 100th Post – A Look Back

By | Leave a Comment

In honor of the O’Neill Institute’s 100th blog post, we present a “top ten” list of some of our most memorable posts: 1. The Supreme Court Upholds the Affordable Care Act Upheld: The Individual Mandate is a Tax. States Have a Choice Whether to Expand Medicaid  (June 2012). 2. New York’s Ban on Large Sodas: […]

Posted in uncategorized ; Tagged: , , , , , , , , , , , , , , , , , , , , , , , , , .

05.23.13

Reforming Food Law in China

By | Leave a Comment

This post was written by Alberto Alemanno, O’Neill Institute Scholar .  It was originally published at http://albertoalemanno.eu/category/blog. Any questions or comments about this post can be directed to alemanno@hec.fr. Barely a day goes by in China without news of yet another food safety scandal. This situation is seriously affecting not only the Chinese’s sentiment of […]

Posted in uncategorized ; Tagged: , , , , , , , , .

05.08.13

Shanghai Visiting Scholars' Presentation on "Drug Sale Management in China"

By | Leave a Comment

On April 24, the O’Neill Institute hosted a presentation by two visiting scholars from the Shanghai Food and Drug Administration (SHFDA).  Mr. Ji Chen is the Deputy Director of the Department of Drug Sale and Marketing Control at the SHFDA headquarters. Mr. Junhua Wu is the Senior Drug Inspection Officer of the Pudong Branch of the SHFDA.

Posted in uncategorized ; Tagged: , , , , , , .

02.15.13

Professor Gostin Chairs and Co-Authors National Academy Report on Dangers of Fake Drugs

By | Leave a Comment

A committee formed by the Institute of Medicine (IOM), National Academy of Science, and chaired by O’Neill Institute for National and Global Health Law Faculty Director and Georgetown University Law Center Professor Lawrence Gostin has issued a new report, “Countering the Problem of Falsified and Substandard Drugs,” which offers recommendations to the United States and […]

Posted in uncategorized ; Tagged: , , , , , , .

12.31.11

Lawsuit Offers Hope that the Plan B OTC Age Restrictions may yet be Lifted

By | Leave a Comment

The fight to make Plan B, an emergency contraceptive, more widely available continues despite Health and Human Services Secretary, Kathleen Sebelius’ decision earlier this month to overrule the FDA’s recommendation that Plan B be made available over-the-counter (OTC) to women and girls of all ages. The Center for Reproductive Rights (CRR) will reopen a lawsuit, […]

Posted in FDA, Healthcare, uncategorized ; Tagged: , , .

12.16.11

Judge invites challenge to HHS decision that blocked access to emergency contraception

By | Leave a Comment

Originally posted at Hunter of Justice on December 14, 2011. The Center for Reproductive Rights announced Tuesday that it will reopen a lawsuit filed in 2005 in order to challenge unnecessary age restrictions on emergency contraceptives imposed last week by the Obama administration. The lawsuit – Tummino v. von Hamburg –  was originally filed against […]

Posted in FDA, Healthcare ; Tagged: , .

11.22.11

Court Enjoins FDA Tobacco Labels

By | Leave a Comment

This post was authored by O’Neill Institute research assistant and third-year Georgetown University Law Center student Mirona Dragnea. On November 7, 2011, District Judge Richard J. Leon of the D.C. District Court sided with five tobacco companies in granting a preliminary injunction in R.J. Reynolds v. U.S. FDA. The decision prohibits the United States Food […]

Posted in FDA, Healthcare, Tobacco, uncategorized ; Tagged: , , , , .

08.01.11

What Does It Mean to Inform?

By | Leave a Comment

This post was authored by Sam Halabi, J.D., M.Phil., Assistant Professor, University of Tulsa College of Law. What Does it Mean to Inform? In response to the graphic warnings released by the U.S. Food and Drug Administration on June 21, 2011, tobacco firms have asserted that the warnings violate their First Amendment rights by forcing […]

Posted in FDA, Tobacco, uncategorized ; Tagged: , , .

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.